Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Ascending
Aug 4, 2008 vagelos p roy Director Disposition (Non Open Market) 114,309 n/a
Aug 4, 2008 vagelos p roy Director Acquisition (Non Open Market) 114,309 n/a
Aug 28, 2008 vagelos p roy Director Disposition (Non Open Market) 8,106 n/a
Oct 6, 2008 vagelos p roy Director Disposition (Non Open Market) 9,270 n/a
Sep 5, 2014 vagelos p roy Officer Disposition (Non Open Market) 4 n/a
Sep 23, 2014 vagelos p roy Officer Disposition (Non Open Market) 7,820 n/a
Oct 1, 2014 vagelos p roy Officer Disposition (Non Open Market) 591 n/a
Apr 1, 2014 vagelos p roy Officer Disposition (Non Open Market) 700 n/a
Jul 1, 2014 vagelos p roy Officer Disposition (Non Open Market) 756 n/a
Jul 5, 2013 vagelos p roy Officer Disposition (Non Open Market) 921 n/a
Oct 1, 2007 vagelos p roy Director Automatic Sell 11,560 n/a
Nov 20, 2007 vagelos p roy Director Automatic Sell 138,737 n/a
Jan 3, 2008 vagelos p roy Director Automatic Sell 8,658 n/a
Mar 29, 2008 vagelos p roy Director Disposition (Non Open Market) 10,669 n/a
Jun 13, 2008 vagelos p roy Director Acquisition (Non Open Market) 115,082 n/a
Nov 17, 2014 vagelos p roy Officer Disposition (Non Open Market) 24,900 n/a
Jan 10, 2014 vagelos p roy Officer Disposition (Non Open Market) 764 n/a
Oct 2, 2013 vagelos p roy Officer Disposition (Non Open Market) 73,596 n/a
Oct 9, 2013 vagelos p roy Officer Disposition (Non Open Market) 679 n/a
Sep 4, 2012 vagelos p roy Officer Disposition (Non Open Market) 19,947 n/a
Showing 101-120 of 887 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)